On Aug. 11, 2011, Genomeon was established under the laws of the Commonwealth of Virginia by Dr. Harold R. Garner and Michael B. Waitzkin to commercialize Dr. Garner’s discoveries regarding microsatellites in the genome.

Blending the power of AI with the precision of genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development.